The Rise of GLP-1 Injectable Therapy: Transforming the Landscape of American HealthcareIn the last years, few medical advancements have captured the public creativity and the pharmaceutical market quite like Glucagon-like peptide-1 (GLP-1) receptor agonists. Originally established to treat Type 2 diabetes, these injectable therapies have actually developed into a cornerstone
